Heat, not knife: new trial aims to cure thyroid cancer in 30 minutes
NCT ID NCT07376837
First seen Jan 30, 2026 · Last updated May 26, 2026 · Updated 14 times
Summary
This study tests whether a minimally invasive procedure called radiofrequency ablation (RFA) can cure small, low-risk papillary thyroid cancers. Thirty adults who decline surgery or active surveillance will receive ultrasound-guided RFA, which uses heat to destroy the tumor. Researchers will check for cancer clearance with a biopsy at 6-12 months and monitor safety and quality of life over a year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID PAPILLARY CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Health Network - Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.